ReviewMaterials today. Bio2025
Low-dimensional nanomaterials for electrochemical biosensing of gastric cancer biomarkers in whole blood: Current trends and future Prospects.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cascade-driven dual-signal attenuation antifouling immunosensor for femtogram-level sensing for SCCA.Analytical and bioanalytical chemistry · 2026Article
- Bibliometric and visualized analysis of nanomedicine research trends for gastric cancer during the early 21st century.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is one of the malignant tumors with a high global incidence and is one of the major public health challenges worldwide. The early diagnosis of gastric cancer has the potential to significantly enhance patient survival rates. Electrochemical biosensors possess the capability to detect biomarkers at low concentrations in whole blood samples, which has sparked considerable interest in their potential clinical applications. This review provides an overview of the role of structural diversity of low dimensional nanomaterials on the sensitivity and specificity approach of electrochemical biosensors. Furthermore, we highlight recent advancements in the development of electrochemical sensors for the detection of various gastric cancer biomarkers in blood samples. This review elucidates the design principles and performance metrics of these sensors, including their sensitivity and specificity. Finally, we address the issues currently encountered by electrochemical biosensors in the detection of gastric cancer and discusses the barriers to their clinical application, and propose potential solutions to these challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.